Johnson & Johnson is an impeccable dividend stock with a streak of 63 consecutive dividend raises. The company's long history of payout increases is another piece of evidence that points to the ...

In this video, Susana M. Campos, MD, MPH, discusses results from a phase 2 trial of pembrolizumab and lenvatinib for patients with recurrent or persistent clear-cell ovarian cancer.Findings from the ...

Alvotech and Dr. Reddy’s have entered into a collaboration and license agreement to co-develop, manufacture and commercialize ...